Max Warncke

631 total citations
9 papers, 329 citations indexed

About

Max Warncke is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Max Warncke has authored 9 papers receiving a total of 329 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 4 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Max Warncke's work include Immunotherapy and Immune Responses (5 papers), T-cell and B-cell Immunology (5 papers) and CAR-T cell therapy research (3 papers). Max Warncke is often cited by papers focused on Immunotherapy and Immune Responses (5 papers), T-cell and B-cell Immunology (5 papers) and CAR-T cell therapy research (3 papers). Max Warncke collaborates with scholars based in Switzerland, Germany and Netherlands. Max Warncke's co-authors include Frank Kolbinger, Christoph Heusser, Thomas Calzascia, M. Coulot, Kirsten D. Mertz, Kea Martin, Ulrike Naumann, Sabina Pfister, Guglielmo Roma and Martin Beibel and has published in prestigious journals such as Blood, The Journal of Immunology and Biochemical and Biophysical Research Communications.

In The Last Decade

Max Warncke

9 papers receiving 322 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Max Warncke Switzerland 6 180 93 84 52 50 9 329
Ehtisham Akhter United States 9 325 1.8× 82 0.9× 85 1.0× 35 0.7× 37 0.7× 11 527
Cai Yue China 11 159 0.9× 106 1.1× 34 0.4× 39 0.8× 51 1.0× 24 372
Mitsuhiko Tanaka Japan 6 163 0.9× 60 0.6× 101 1.2× 16 0.3× 42 0.8× 12 286
Matthew W. Anderson United States 7 168 0.9× 72 0.8× 24 0.3× 36 0.7× 38 0.8× 12 281
Yong‐Wook Park South Korea 10 251 1.4× 42 0.5× 36 0.4× 20 0.4× 71 1.4× 13 445
Emma MacDermott Ireland 7 164 0.9× 64 0.7× 24 0.3× 61 1.2× 18 0.4× 18 334
Francesca Miranda Italy 11 140 0.8× 63 0.7× 56 0.7× 20 0.4× 26 0.5× 19 323
Andrea G. Bree United States 7 169 0.9× 160 1.7× 34 0.4× 29 0.6× 32 0.6× 12 352
D F Huang Taiwan 9 186 1.0× 39 0.4× 116 1.4× 12 0.2× 55 1.1× 12 308
Iván Posso‐Osorio Colombia 11 112 0.6× 52 0.6× 30 0.4× 24 0.5× 20 0.4× 55 326

Countries citing papers authored by Max Warncke

Since Specialization
Citations

This map shows the geographic impact of Max Warncke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Warncke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Warncke more than expected).

Fields of papers citing papers by Max Warncke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Max Warncke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Warncke. The network helps show where Max Warncke may publish in the future.

Co-authorship network of co-authors of Max Warncke

This figure shows the co-authorship network connecting the top 25 collaborators of Max Warncke. A scholar is included among the top collaborators of Max Warncke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Max Warncke. Max Warncke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Beibel, Martin, Kea Martin, Rachel Cuttat, et al.. (2020). Immune cell landscaping reveals a protective role for regulatory T cells during kidney injury and fibrosis. JCI Insight. 5(3). 111 indexed citations
2.
Espié, Pascal, Peter Ulrich, Denise Sickert, et al.. (2018). Characterization of the in vitro and in vivo properties of CFZ533, a blocking and non-depleting anti-CD40 monoclonal antibody. American Journal of Transplantation. 18(12). 2895–2904. 74 indexed citations
4.
Warncke, Max, et al.. (2012). Different Adaptations of IgG Effector Function in Human and Nonhuman Primates and Implications for Therapeutic Antibody Treatment. The Journal of Immunology. 188(9). 4405–4411. 72 indexed citations
5.
Warncke, Max, Maike Buchner, Anna Dodero, et al.. (2010). Control of the specificity of T cell-mediated anti-idiotype immunity by natural regulatory T cells. Cancer Immunology Immunotherapy. 60(1). 49–60. 12 indexed citations
6.
Vogt, Birgit, Max Warncke, Burkhard Micheel, & Ahmed Sheriff. (2009). Lentiviral gene transfer of CTLA4 generates B cells with reduced costimulatory properties. Autoimmunity. 42(4). 380–382. 5 indexed citations
8.
Warncke, Max, Anna Dodero, Heide Dierbach, Marie Follo, & Hendrik Veelken. (2005). Murine dendritic cells generated under serum-free conditions have a mature phenotype and efficiently induce primary immune responses. Journal of Immunological Methods. 310(1-2). 1–11. 15 indexed citations
9.
Warncke, Max, Birgit Vogt, Winfried Beyer, et al.. (2004). Efficient in vitro transduction of naive murine B cells with lentiviral vectors. Biochemical and Biophysical Research Communications. 318(3). 673–679. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026